Correlation Between Regeneron Pharmaceuticals and Gemina Laboratories
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Gemina Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Gemina Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Gemina Laboratories, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Gemina Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Gemina Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Gemina Laboratories.
Diversification Opportunities for Regeneron Pharmaceuticals and Gemina Laboratories
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Regeneron and Gemina is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Gemina Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gemina Laboratories and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Gemina Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gemina Laboratories has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Gemina Laboratories go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and Gemina Laboratories
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Gemina Laboratories. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 4.07 times less risky than Gemina Laboratories. The stock trades about -0.36 of its potential returns per unit of risk. The Gemina Laboratories is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 31.00 in Gemina Laboratories on September 12, 2024 and sell it today you would earn a total of 24.00 from holding Gemina Laboratories or generate 77.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 98.44% |
| Values | Daily Returns |
Regeneron Pharmaceuticals vs. Gemina Laboratories
Performance |
| Timeline |
| Regeneron Pharmaceuticals |
| Gemina Laboratories |
Regeneron Pharmaceuticals and Gemina Laboratories Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Regeneron Pharmaceuticals and Gemina Laboratories
The main advantage of trading using opposite Regeneron Pharmaceuticals and Gemina Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Gemina Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gemina Laboratories will offset losses from the drop in Gemina Laboratories' long position.| Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
| Gemina Laboratories vs. Sino Biopharmaceutical Ltd | Gemina Laboratories vs. Defence Therapeutics | Gemina Laboratories vs. Aileron Therapeutics | Gemina Laboratories vs. Enlivex Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |